Completed PHASE3 INTERVENTIONAL 4-arm NCT00610272

Optimization of Radiotherapy in Treatment of Painful Bone Metastasis (bone mets)

Investigation of Optimal Radiotherapy Regimen and Type of Irradiation in Treatment of Painful Bone Metastasis

Sponsor: International Atomic Energy Agency

Updated 6 times since 2017 Last updated: Aug 6, 2013 Started: Jan 31, 2008 Primary completion: Apr 30, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Bone Metastasis and Pain and is currently completed. International Atomic Energy Agency leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International Atomic Energy Agency

Data source: International Atomic Energy Agency

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Algiers, Algeria , Barcelona, Spain , Belgrade, Serbia , Cairo, Egypt , Mexico City, Mexico , Mumbai, India , Northwood, United Kingdom , Palma de Mallorca, Spain , Porto Alegre, Brazil , Skopje, North Macedonia and 2 more locations